Ventricular tachycardia: vizsgálatok itt: Norvégia
1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleSafety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
- Where
- Oslo
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Agiana Pharmaceuticals
See details and how to joinNCT07263139 · EU 2025-521611-39-00